Oncorus, Inc.
ONCRDelisted Jul 10, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001671818
Oncorus, Inc. was delisted on Jul 10, 2023; its insiders filed their last Form 4 on Dec 30, 2022; 32 institutions reported holding it in 13F filings for Q1 2023, worth $3.78M in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in Oncorus, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 33
- −7 vs. Q3 2022
- Shares held
- 15.6M
- −918.6K (−5.6%) vs. Q3 2022
- Total value
- $3.95M
- −$10.1M (−71.9%) vs. Q3 2022
- New holders
- 1
- 8 more added
- Sold out
- 8
- 15 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ONCR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 1 | $3 |
| Q2 2023 | 4 | $212.1K |
| Q1 2023 | 32 | $3.78M |
| Q4 2022 | 33 | $3.95M |
| Q3 2022 | 40 | $14.1M |
| Q2 2022 | 45 | $21.4M |
| Q1 2022 | 56 | $34.5M |
| Q4 2021 | 56 | $107.1M |
| Q3 2021 | 48 | $186.2M |
| Q2 2021 | 50 | $282.6M |
| Q1 2021 | 57 | $278.2M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Oncorus, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| MPM Asset Management LLC | 2,849,464 | $720.9K | 0.30% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 2,536,186 | $642.4K | 0.01% | −612,791−19.5% | Reduced |
| MPM Oncology Impact Management LP | 2,377,031 | $601.4K | 0.16% | 00.0% | Unchanged |
| CHI Advisors LLC | 2,367,436 | $599.7K | 0.16% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,924,422 | $487.5K | 0.00% | +9,828+0.5% | Added |
| Fosun International Ltd | 962,323 | $243.8K | 0.02% | 00.0% | Unchanged |
| Sphera Funds Management Ltd. | 540,258 | $136.8K | 0.04% | 00.0% | Unchanged |
| Vanguard Group Inc | 495,913 | $125.6K | 0.00% | −401−0.1% | Reduced |
| Renaissance Technologies LLC | 286,936 | $73.0K | 0.00% | +77,403+36.9% | Added |
| Millennium Management LLC | 276,358 | $70.0K | 0.00% | −91,668−24.9% | Reduced |
| BlackRock Inc. | 139,672 | $35.4K | 0.00% | −132,692−48.7% | Reduced |
| Geode Capital Management, LLC | 137,927 | $34.0K | 0.00% | −299−0.2% | Reduced |
| We Are One Seven, LLC | 116,354 | $29.5K | 0.00% | −350.0% | Reduced |
| Two Sigma Advisers, LP | 99,200 | $25.1K | 0.00% | −8,900−8.2% | Reduced |
| SG Americas Securities, LLC | 72,692 | $18.0K | 0.00% | +36,355+100.0% | Added |
| State Street Corp | 70,135 | $17.8K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 67,300 | $17.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 66,498 | $16.8K | 0.00% | −497−0.7% | Reduced |
| Two Sigma Investments, LP | 62,792 | $15.9K | 0.00% | −18,700−22.9% | Reduced |
| Bank of America Corp | 44,788 | $11.3K | 0.00% | +32,026+250.9% | Added |
| Northern Trust Corp | 28,960 | $7.34K | 0.00% | 00.0% | Unchanged |
| HSBC Holdings PLC | 26,452 | $7.14K | 0.00% | +32+0.1% | Added |
| Goldman Sachs Group Inc | 17,189 | $4.35K | 0.00% | −7,222−29.6% | Reduced |
| Ergoteles LLC | 14,707 | $3.73K | 0.00% | −71,428−82.9% | Reduced |
| Jane Street Group, LLC | 11,972 | $3.03K | 0.00% | +11,972 | New |
| Barclays PLC | 9,495 | $2.40K | 0.00% | −866−8.4% | Reduced |
| Morgan Stanley | 8,394 | $2.13K | 0.00% | −6,995−45.5% | Reduced |
| Tower Research Capital LLC (TRC) | 8,602 | $2.00K | 0.00% | −2,555−22.9% | Reduced |
| Citigroup Inc | 506 | $128 | 0.00% | +15+3.1% | Added |
| Wells Fargo & Company | 133 | $34 | 0.00% | +4+3.1% | Added |
| Your Advocates Ltd., LLP | 100 | $25 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 353 | $0 | 0.00% | −953−73.0% | Reduced |
| Royal Bank of Canada | 228 | $0 | 0.00% | +3+1.3% | Added |
| Letko, Brosseau & Associates Inc | 0 | $0 | 0.00% | −59,150−100.0% | Sold out |
| Sawtooth Solutions, LLC | 0 | $0 | 0.00% | −36,748−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −15,874−100.0% | Sold out |
| Assenagon Asset Management S.A. | 0 | $0 | 0.00% | −13,642−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −3,604−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −905−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −83−100.0% | Sold out |
| China Universal Asset Management Co., Ltd. | 0 | $0 | 0.00% | −243−100.0% | Sold out |